Table 3 Patient characteristics by MRA discharge prescription
|  | Total N = 1500 | MRA after Hospitalization n = 375 | No MRA after Hospitalization n = 1125 | p-value |
|---|---|---|---|---|
Demographics | ||||
 Age, Mean ± SD | 71.9 ± 13.6 | 69.7 ± 13.6 | 72.6 ± 13.2 | 0.0003 |
 Female | 443 (29.5%) | 108 (28.8%) | 335 (29.8%) | 0.7193 |
 Black | 227 (15.1%) | 67 (17.9%) | 160 (14.2%) | 0.0881 |
 Hispanic | 97 (6.5%) | 37 (9.9%) | 60 (5.3%) | 0.0020 |
Comorbid conditions | ||||
 Hypertension | 1151 (76.7%) | 282 (75.2%) | 869 (77.2%) | 0.4171 |
 Atrial fibrillation | 792 (52.8%) | 202 (53.9%) | 590 (52.4%) | 0.6328 |
 Diabetes mellitus | 617 (41.1%) | 166 (44.3%) | 451 (40.1%) | 0.1545 |
 Chronic kidney disease | 511 (34.1%) | 117 (31.2%) | 394 (35.0%) | 0.1762 |
 Malignancy | 325 (21.7%) | 65 (17.3%) | 260 (23.1%) | 0.0187 |
 COPD | 244 (16.3%) | 57 (15.2%) | 187 (16.6%) | 0.5181 |
 Myocardial infarction | 241 (16.1%) | 61 (16.3%) | 180 (16.0%) | 0.9031 |
 Cerebrovascular disease | 204 (13.6%) | 39 (10.4%) | 165 (14.7%) | 0.0369 |
 Peripheral vascular disease | 170 (11.3%) | 37 (9.9%) | 133 (11.8%) | 0.3009 |
 Dementia | 141 (9.4%) | 30 (8.0%) | 111 (9.9%) | 0.2834 |
 Cirrhosis | 27 (1.8%) | 4 (1.1%) | 23 (2.0%) | 0.2174 |
 LVEF %, Mean ± SD | 26.4 ± 7.2 | 23.9 ± 7.0 | 27.3 ± 7.1 | <0.0001 |
Admission Blood Pressure, Labs, & Home Medications | ||||
 Admission Systolic blood pressure, Mean ± SD | 130.7 ± 23.8 | 128.6 ± 23.3 | 131.4 ± 23.9 | 0.0475 |
 Sodium, Mean ± SD | 137.4 ± 4.4 | 137.6 ± 4.1 | 137.4 ± 4.6 | 0.3131 |
 Potassium, Mean ± SD | 4.4 ± 0.6 | 4.4 ± 0.6 | 4.4 ± 0.6 | 0.7813 |
 Creatinine, Mean ± SD | 1.2 ± 0.5 | 1.2 ± 0.5 | 1.2 ± 0.5 | 0.6580 |
 eGFR, Mean ± SD | 63.6 ± 24.9 | 64.6 ± 23.3 | 63.3 ± 25.4 | 0.3398 |
 ACE Inhibitor or ARB | 882 (58.8%) | 248 (66.1%) | 634 (56.4%) | 0.0009 |
 Beta blocker | 1095 (73.0%) | 298 (79.5%) | 797 (70.8%) | 0.0011 |
 Loop diuretic | 864 (57.6%) | 262 (69.9%) | 602 (53.5%) | <0.0001 |
Discharge Labs & Home Medications | ||||
 Creatinine, Mean ± SD | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.1 ± 0.4 | 0.0817 |
 eGFR, Mean ± SD | 65.4 ± 24.0 | 64.7 ± 23.6 | 65.6 ± 24.1 | 0.5497 |
 Potassium, Mean ± SD | 4.2 ± 0.4 | 4.2 ± 0.4 | 4.2 ± 0.4 | 0.9968 |
 ACE Inhibitor or ARB | 975 (65.0%) | 279 (74.4%) | 696 (61.9%) | <0.0001 |
 Beta blocker | 1184 (78.9%) | 336 (89.6%) | 848 (75.4%) | <0.0001 |
 Loop diuretic | 1022 (68.1%) | 315 (84.0%) | 707 (62.8%) | <0.0001 |
Primary Service* | ||||
 Cardiology | 668 (44.5%) | 203 (54.1%) | 465 (41.3%) | <0.0001 |
 Medicine | 411 (27.4%) | 82 (21.9%) | 329 (29.2%) | 0.006 |
 Other | 395 (26.3%) | 86 (22.9%) | 309 (27.5%) | 0.08 |